The authors describe an assay to measure the generation of adenosine 5´-diphosphate (ADP) resulting from phosphorylation of a substrate by a kinase. ADP accumulation is detected by conversion to a fluorescent signal via a coupled enzyme system. The technology has potential applications for the assessment of inhibitor potency and mode of action as well as kinetic analysis of enzyme activity. The assay has a wide dynamic range (0.25-75 µM) and has been validated with several kinases including the highly active cyclic adenosine monophosphate-dependent protein kinase (PKAα), casein kinase 1 (CK1), and the weakly active kinase Jun N-terminal kinase 2 (Jnk2α2). Kinase activity can be measured either in an end point or continuous mode. Assay performance in end point mode was compared with an adenosine 5´-triphosphate (ATP) depletion assay and in continuous mode with a pyruvate kinase/lactate dehydrogenase coupled assay. The ability to characterize kinase kinetics was demonstrated by deriving ATP/substrate affinity (Michaelis-Menten constant; K m ) values for PKAα, CK1, and Jnk2α2. The assay readily measured activity with kinase reactions using protein substrates, indicating the suitability for use with large macromolecules. A wide range of inhibitor activities could be determined even in the presence of high ATP concentrations, making the assay highly suitable to characterize the mode of action of the inhibitor in question. Collectively, this assay provides a homogenous, generic method for a number of applications in kinase drug discovery. (Journal of Biomolecular Screening 2006:390-399) 
INTRODUCTION

M
ORE THAN 500 PROTEIN KINASES have now been identified and appear to comprise approximately 2% of the human genome. 1 As mediators of eukaryotic signal transduction controlling multiple cellular processes, such as gene transcription, cell cycling, migration, apoptosis, and differentiation, protein kinases are considered important targets in drug discovery. Aberrant kinase functions are associated with neoplasias, including metastasis, psoriasis, and liver fibrosis. 2, 3 Several kinase inhibitors such as STI 571 (Gleevec 4 ), for the treatment of chronic myelogenous leukemia, 5, 6 ZD 1839 problem, which use fluorophore-labeled substrates together with functionalized beads or polymers. These contain metal chelates that selectively bind labeled phosphopeptide product with a concomitant change in fluorescence intensity or polarization. 18, 19 Alternatively, fluorescence resonance energy transfer-based assays employ a specific protease that is sensitive to the phosphorylation state of a peptide substrate. 20 Although these methods offer the advantage that they do not require specific antibodies, they still require modified substrates, are typically less sensitive than immunoassays, and, in the case of affinity-based capture assays, are prone to nonspecific phosphate binding. 13, 21 Attention has recently focused on the measurement of either ATP consumption or adenosine 5´-diphosphate (ADP) accumulation as more generic approaches. The reduction in ATP concentration resulting from kinase activity can be quantified using a luciferin/luciferase enzyme system, which generates a chemiluminescent signal. 22 An advantage of this technology for inhibitor screening is that increased sensitivity is achieved through reducing the ATP concentration in the reaction. However, the assay is limited in that at least 20% to 30% hydrolysis of ATP is required to provide a meaningful assay window, making it unsuitable for those kinase assays requiring high concentrations of ATP, particularly at ATP concentrations above the MichaelisMenten constant (K m ) for the luciferase. Moreover, artifactual interferences due to library compounds acting on the detection enzymes have been reported, 23 and the inability to measure kinase kinetics, due to dependency of signal generation on ATP, restricts the use of the assay in mode-of-action studies.
An alternative approach, therefore, is to measure the generation of ADP occurring in a kinase reaction. This has been achieved using an enzyme-coupled system that produces a sensitive fluorescent or colorimetric signal. 24 The approach uses a coupled pyruvate kinase-lactate dehydrogenase (LDH) system in which ADP and phosphoenolpyruvate (PEP) are converted to pyruvate and ATP. The pyruvate is then converted to lactic acid by LDH, resulting in oxidation of β-nicotinamide adenine dinucleotide, reduced form (NADH), the concentration of which is measured by either absorbance or fluorescence detection. However, in this protocol, the assay signal decreases with kinase activity and requires monitoring by absorbance or fluorescence at emission wavelengths susceptible to compound interference. Moreover, the assay signal may be affected by significant signal drift due to the decomposition of NADH induced by UV light. 25 The assay described in this article allows detection of ADP accumulation via a positive fluorescent signal at wavelengths less prone to compound interference. 26, 27 ADP is measured by a coupled enzyme reaction with pyruvate kinase and pyruvate oxidase to convert ADP to hydrogen peroxide, which is detected using a fluorogenic substrate and horseradish peroxidase. The performance of the assay is examined, and potential applications in kinase characterization, substrate analysis, and inhibitor profiling are assessed.
MATERIALS AND METHODS
Materials
All kinases used in this study were obtained from either Upstate Biotechnology (Charlottesville, VA) or EMD Biosciences (San Diego, CA). The peptide substrates used for cyclic adenosine monophosphate-dependent protein kinase/protein kinase A (PKA α ), casein kinase 1 (CK1), Jun N-terminal kinase 2 (Jnk2α2), and mitogen-activated protein (MAP) kinase 1 were kemptide (LRRASLG), CK-1 (RKDLHDDEEDEAMSITA), ATF-2 (VADQTPTPTRFLK), and MBP-17mer (FFKNIVT-PRTPPPSQGK), respectively, and were purchased from American Peptide Company (Sunnyvale, CA). Surfact-Amps Tween 20 with minimal peroxide content was purchased from Pierce Biotechnology (Rockford, IL). Ultrapure ATP (Cat. #A7699) and all other reagents were obtained from SigmaAldrich (St. Louis, MO). Black 384-well assay plates were obtained from Greiner (Longwood, FL), and TopSeal-A Sealing Film was purchased from Packard Instrument Company (Meriden, CT).
The ADP Quest assay kit, composed of ADP reagent A, ADP reagent B, ADP standard, and assay buffer, was obtained from DiscoveRx Corp (Fremont, CA). Reagent A contains 50 mM phosphate buffer, pH 7.0, 250 µM Amplex Red (SynChem, Des Plaines, IL), and 1 U/ml catalase. Reagent B contains 50 mM phosphate buffer, pH 7.0, 2.5 mM MgCl 2 , 25 µM flavine adenine dinucleotide, 250 µM thiamine pyrophosphate, 250 µM PEP, 25 U/ml horseradish peroxidase (Calzyme, San Luis Obispo, CA), 50 U/ml pyruvate kinase (Calzyme), 15 U/ml pyruvate oxidase (Genzyme, Cambridge, MA), and 1 U/ml catalase.
Kinase activity determination
All kinase reactions, enzyme, and standard dilutions were performed in assay buffer containing 15 mM Hepes, 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl 2 , 0.1% bovine γ-globulins, pH 7.4. Kinase reactions and standard curves were performed in 20-µl volumes and incubated at 30°C in sealed black 384-well plates for the specified time period. For kinase activity curves, the enzymes were serially diluted in assay buffer and incubated in the presence of peptide substrate (100 µM kemptide, 100 µM ATF-2, or 400 µM CK1) and ATP (100 µM for all kinases) for 1 h. ADP product was measured as described below.
Comparison with other assays
ADP Quest continuous mode assay. Serially diluted PKA kinase and 40 µM kemptide substrate in a final volume of 15 µl in assay buffer were combined with 10 µl ADP reagent A and 20 µl ADP reagent B. To initiate the kinase reaction, 5 µl 400 µM ATP was added, and activity was monitored every 2 min using a ATP depletion assay. Casein kinase 1 was serially diluted in assay buffer and incubated in the presence of 250 µM CK1 peptide substrate and varying amounts of ATP for 1 h at 30° C in an assay volume of 20 µl and a white 384-well plate (Costar). A total of 20 µl Kinase-Glo reagent (Promega, Madison, WI) was added and incubated for 15 min at room temperature. Chemiluminescence signal was measured using a Packard Lumicount plate reader with 1-s integration at 750 V PMT voltage. Duplicate assays were performed in a black 384-well plate, and ADP product was measured using the ADP assay as described below.
ATP and substrate K m determination
For ATP dependency studies, ATP was serially diluted and incubated with either 200 µM kemptide peptide substrate and 10 ng/ml (0.25 nM) PKAα for 30 min, 200 µM CK1 peptide substrate, and 30 ng/ml (0.9 nM) CK1 for 60 min or 200 µM ATF-2 peptide substrate and 50 ng/ml (1 nM) Jnk2α2 for 60 min. For peptide substrate titration studies, the substrate was serially diluted and incubated with 200 µM ATP and 10 ng/ml (0.25 nM) PKAα for 30 min. In some cases, kinase activity was stopped by the addition of 5 µl 50 mM EDTA prior to the addition of detection reagents. ADP product was measured as described below.
Kinase inhibitor studies
For inhibition curves, staurosporine was serially diluted and incubated for 1 h with 20 ng/ml (0.49 nM) PKAα, 100 ng/ml CK1 (2.9 nM), or Jnk2α2 (2 nM) in the presence of ATP and peptide substrate each at 25 µM (PKAα), 50 µM (CK1), or 25 µM (Jnk2α2). To determine K i values, ATP was serially diluted and incubated with 25 µM kemptide peptide substrate and 20 ng/ml PKAα for 60 min in the presence of varying concentrations of staurosporine. ADP product was measured as described below.
Whole protein substrates
For substrate dependency studies, 25 µM myelin basic protein (MBP) whole protein (Sigma) or 50 µM MBP-17mer peptide substrates were incubated with serially diluted MAP kinase 1 (Upstate, Waltham, MA) in the presence of 200 µM ATP for 60 min. ADP product was measured as described below.
ADP determination
ADP concentration was determined by the addition of 10 µl ADP reagent A and 20 µl ADP reagent B to 20 µl of kinase reaction mixture or ADP standard and incubated at room temperature for 30 min. ADP standard curves were performed by serially diluting ADP standard in assay buffer. The fluorescent signal was measured with a Packard Fluorocount plate reader using 0.10-s integration at 750 V PMT voltage and excitation and emission wavelengths of 530 and 590 nm, respectively. All values shown reflect the ADP concentration in the analyte reaction volume (20 µl) rather than the final system volume (50 µl).
Data analysis
Data were plotted using Prism software (GraphPad Software Inc., San Diego, CA). Assay sensitivity in terms of lowest detectable ADP concentration was calculated as the concentration of ADP that generated a signal 3 standard deviations (SDs) above the mean assay background. For enzyme and inhibitor dose curves, the data were analyzed using nonlinear iterative regression analysis fitted to a 4-parameter single-site binding model. For analysis of the effect of substrate concentrations on enzyme kinetics, the signal obtained was converted to rate ([RFU -RFU control ]/time) and plotted against substrate concentration. RFU control is the signal obtained in the absence of kinase at the respective ATP concentration. The data were fitted to the Michaelis-Menten equation to obtain K m values (equation 1):
Inhibitor K i was derived by plotting the effect of varying ATP concentration (S) on enzyme activity in the presence of varying concentrations of inhibitor (I). The data were fitted using global nonlinear regression for competitive, noncompetitive, and uncompetitive inhibition models (equations 2-4), where K obs is the apparent or observed K m in the presence of inhibitor at concentration (I) and parameters V max , K m , and K i are shared values across the range of inhibitor concentrations tested:
Competitive inhibition
(2)
RESULTS AND DISCUSSION
The assay described in this article is a homogenous, generic assay for measuring kinase activity through the accumulation of ADP. Detection of ADP is achieved through a coupled enzyme reaction involving pyruvate kinase, pyruvate oxidase, and peroxidase ( Fig. 1) . ADP and PEP are converted by pyruvate kinase to ATP and pyruvate, and the pyruvate is oxidized by pyruvate oxidase to generate hydrogen peroxide. Peroxidase catalyzes the oxidation of Amplex Red to generate resorufin, the concentration of which is measured by standard fluorimetry (resorufin: 530 nm excitation/590 nm emission). The measurement of ADP by this enzyme-coupled system has advantages over the classic pyruvate kinase/LDH approach in that a direct relationship between ADP and signal output is observed. Furthermore, the use of fluorescence detection at longer wavelengths reduces compound interference due to quenching or fluorescence.
Assay performance and precision
The assay protocol requires the addition of 2 detection reagents to a kinase reaction, followed by a brief incubation period prior to signal detection (Fig. 1) . The assay has a detection range of 0.25 to 75 µM ADP ( Fig. 2A) . It was observed that there was an optimal read time of 30 min after addition of detection reagents, resulting in a signal-to-background ratio (75 µM v. 0 µM ADP) in excess of 40. The presence of contaminating hydrogen peroxide in the detection reagents that could contribute to the assay background was reduced by the inclusion of catalase at a concentration that did not interfere with ADP detection (data not shown). Background was found to increase over time but can be subtracted to allow for the detection of ADP at 0.25 µM and greater for up to 6 h (data not shown).
The lowest amount of ADP able to be detected by the assay was 0.25 µM (RFU: 202.3 ± 8.5; >3 SD above background: 157.3 ± 5.2 RFU). The linear range of the assay was between 0.25 and 25 µM ADP (r 2 = 0.996). ADP concentration could be quantitated across the full range of the assay using 2nd-order nonlinear regression analysis (R 2 = 0.999). The ability to quantitate ADP in this format suggests that the ADP assay is suitable for in vitro analysis of enzymes that generate ADP, such as kinases and ATPases.
The utility of the assay was examined using 3 prototypic kinases exhibiting a range of activity: cAMP-dependent protein kinase (PKAα), casein kinase 1 (CK1), and Jun N-terminal kinase 2 (Jnk2α2). The kinase reactions were performed in the presence of ATP and appropriate peptide substrate. It was observed that ADP accumulation occurred with all 3 kinases with the expected rank order of specific activity, that is, PKA α > CK1 = Jnk2α2 (Fig. 2B) . A linear relationship between signal output and kinase activity was observed of up to 2 orders of magnitude of enzyme concentration, indicating that the assay is capable of measuring ADP accumulation across a wide dynamic range (Fig. 2B, inset) .
ADP accumulation can also be detected in kinase reactions using a PK/LDH-coupled assay, whereby turnover of ADP is measured by absorbance as a result of NADH turnover. LDH/NADH assays are typically performed as continuous assays in which kinase activity can be monitored online. The ability of the ADP assay to operate as a continuous assay for kinase activity was examined and the performance compared with the LDH assay. A linear change in signal (positive for ADP and negative for the LDH) was measured for both assays, indicating that the initial rates for kinase activity could be Noncompetitive inhibition
Uncompetitive inhibition
determined (Fig. 3A, B) . For the ADP assay, significant kinase activity (3 SD over background rate: ∆RFU/min = 5.560 ± 0.1685) was detected with 0.024 nM PKA (∆RFU/min = 10.73 ± 0.2310), whereas for the LDH assay, detectable kinase activity (3 SD over background rate: ∆OD/min = -0.00035 ± 0.000033) was obtained with 0.24 nM PKA (∆OD/min = -0.00055 ± 0.00007). A linear relationship was obtained between initial rates and enzyme concentration between 0.024 nM and 2.4 nM PKA for the ADP assay and 0.08 nM and 2.4 nM PKA for the LDH assay (Fig. 3C) . It should be noted that for some kinases, activity might be inhibited by the presence of ADP assay reagents (e.g., CK1), and for those situations, an end point assay would be an appropriate alternative. In most cases, however, the ADP assay can be used in continuous assays in a manner similar to the LDH assay with improved sensitivity and the convenience of positive signal generation.
The ADP assay was also compared to an ATP depletion assay to examine the effect of ATP concentration on assay performance. Using casein kinase as an example of an enzyme with a 
FIG. 3.
Comparison of lactate dehydrogenase (LDH) and adenosine 5´-diphosphate (ADP) assays in a continuous kinase assay. Protein kinase A was incubated with 100 µM adenosine 5´-triphosphate (ATP) and kemptide substrate in the presence of either ADP assay or LDH assay detection reagents as described in the "Methods" section, and kinase activity was monitored online by fluorescence (for ADP assay) or by absorbance (for LDH assay). (A, B) Kinase time course for the ADP and LDH assays, respectively. Data shown are the linear portion of the assays (initial rates) and are mean ± SEM (n = 2-3). (C) Relationship between initial rates and kinase concentration for the ADP and LDH assay. RFU = relative fluorescence unit.
relatively high K m for ATP, enzyme activity was measured using a range of ATP concentrations. For the ADP assay, significant enzyme activity could be detected with 0.06 nM CK1 using 10 µM ATP (472 ± 16 RFU over background of 323 ± 19 RFU; Fig. 4A ), whereas the lowest detectable activity using the ATP depletion assay was achieved with 0.19 nM CK1 in the presence of 1 µM ATP (Fig. 4B) . The EC 50 for the ATP depletion assay increased with ATP concentration (0.64 nM CK1 at 1 µM to 3 nM CK1 at 50 µM) but was constant for the ADP assay (0.7 nM CK1 at 10 µM ATP to 0.9 nM CK1 at 50 µM ATP). Therefore, the ADP assay offers considerable advantages over the ATP depletion assay in terms of sensitivity when used with kinases of high ATP dependencies. It was observed that ATP present in kinase reactions contributed to assay background, probably due to trace ADP contamination in the ATP stock solutions. As a result, the quality of ATP reagent can have a major impact on assay background. Therefore, an ultrapure source of ATP was used in kinase reactions that minimize the amount of contaminating ADP (see the "Methods" section). In the PKAα assay shown in Figure 2B , 100 µM ATP contributed 125 ± 3 RFU above an assay background of 165 ± 6 RFU, which is equivalent to 1 µM ADP. As a consequence of increased background, the signal-to-background ratio was reduced by 30%, demonstrating that although ATP stocks contained trace amounts of contaminating ADP, enzyme reactions may be performed at high ATP concentrations with only a modest impact on assay performance. This degree of ATP tolerance is particularly useful for studying enzyme kinetics or with kinases that exhibit high ATP dependencies.
As some kinase assays require reducing agents, such as DTT, to attenuate enzyme inactivation, the effect of DTT on assay performance was studied. It was found that DTT markedly increased background signal of the ADP assay (Fig. 5A) . As a result, the minimal concentration of ADP that could be detected above the assay background in the presence of 1 mM DTT was 2.5 µM (Fig. 5C) . Therefore, the use of reducing agents in kinase reactions would likely affect ADP detection by truncating assay sensitivity and performance. Diamide is a compound that eliminates DTT, 28 and the utility of this agent was investigated. The addition of excess diamide, followed by a brief incubation prior to ADP detection, decreased the effect of DTT on the assay background signal (Fig. 5A) . A minimum of equimolar diamide was required to eliminate DTT from solution (Fig. 5B) . In the presence of DTT and a 2-fold excess of diamide, the lowest concentration of ADP that could be detected by the assay was 0.79 µM (Fig. 5C) . Therefore, in cases in which DTT is essential for kinase activity, diamide can be added at the end of the kinase reaction step in 2-fold excess to eliminate the reducing agent prior to ADP detection. However, it should be noted that assay sensitivity could be reduced as a result.
Characterization of kinase activities
Several studies were undertaken to demonstrate the utility of the assay in measuring kinase activities. The kinetics of PKAα activity was examined using the ADP assay to determine the K m for ATP and the peptide substrates. Pilot experiments were performed to ensure that over the course of the experiment, kinase activity was operating at the initial rate and that product formation was less than 10% of the available substrates. In the presence of excess kemptide substrate (200 µM), a K m for ATP of 29.9 ± 2.4 µM was obtained compared to published values using either 
FIG. 4.
Comparison of adenosine 5´-diphosphate (ADP) accumulation and adenosine 5´-triphosphate (ATP) depletion assays using casein kinase 1 (CK1). CK1 was incubated with 1 to 50 µM ATP and 250 µM CK1 substrate for 1 h at 30° C. ADP accumulation or ATP depletion detection reagents were added as described in the "Methods" section and kinase activity monitored online by fluorescence (for ADP assay) or by chemiluminescence (for ATP depletion assay). (A, B) The effect of ATP concentration on detection of kinase activity using the ADP accumulation and ATP depletion assays, respectively. Data shown are mean ± SEM (n = 3).
radioactive phosphate labeling of substrate (21.2 µM) 29 or ADP detection via a pyruvate kinase/LDH-coupled assay (20.4 µM 30 ; Fig. 6A) . Differences in the assay conditions may account for higher ATP K m values obtained using the ADP assay. In the presence of excess ATP, a K m of 13.8 ± 1.2 µM for kemptide was determined, which is also comparable to earlier reports (16 µM 31 ; Fig. 6B ). To inhibit kinase activity during ADP detection, the experiments were carried out with the addition of 10 mM EDTA prior to addition of ADP assay reagents. EDTA had no significant impact on the ADP assay (Fig. 5D) and effected an 85% inhibition of kinase activity (Fig. 5E) .
Because CK1 was inhibited by the presence of the assay detection reagents, EDTA was not required (Fig. 5F) . A K m value for ATP of 46.4 ± 3.2 µM was determined using the substrate RKDLHDDEEDEAMSITA 32 (Fig. 6C) . Similar values of 31 to 34 µM have been reported for yeast CK1 using the peptide DDDEESITRR. 33 Finally, a K m of 24.4 ± 0.8 µM for ATP was obtained with Jnk2α2 kinase (Fig. 6D) . These data highlight the utility of the assay to measure kinase kinetics with a range of activities.
Kinase assays that rely on peptides modified with a label are restricted in the availability and size of the substrate that can be successfully used with the technology. Indeed, peptide substrates may be poor replacements for the endogenous proteins either in terms of kinase activity or in terms of differential modulation by novel inhibitors. We reasoned that the substrate requirements would be more general in an assay format that measures ADP accumulation. Therefore, the activity of MAP kinase 1 was compared using 2 substrates: an 18.4 kDa MBP and a 17-amino-acid peptide derived from the MBP sequence (MBP-17mer). It was observed that MAP kinase 1 activity was enhanced 10-fold in the presence of MBP protein substrate, compared to the peptide substrate (Fig. 6E) . The preference of MAP kinase for MBP over a short peptide may be due to the conformational binding requirements, the presence of multiple phosphorylation sites, or differences in net charge that may influence the K m of the enzyme for the substrate.
Overall, these data show that the ADP accumulation assay provides a useful technology for measuring kinase activity and assessing ATP and substrate kinetics. The assay tolerance to relatively high ATP concentrations, combined with a simple homogenous protocol, suggests that it is adaptable to automated fluid dispensing systems used in high-throughput screening (HTS). The ability to measure activity using protein substrates highlights an additional utility of the assay. In particular, these include macromolecule substrates to study phosphorylation, autophosphorylation, and kinase phosphorylation of lipids.
Characterization of inhibitor activities
The characterization of kinase inhibitor potency and mode of action is an important use of activity assays in drug discovery. The effect of 10 mM EDTA on ADP detection using the ADP assay. ADP was serially diluted in assay buffer. A total of 5 µl of 50 mM EDTA or assay buffer was added. ADP detection was then performed as described in the "Methods" section. Data shown are corrected for background and are mean ± SEM (n = 3). (E) Effect of ADP assay reagents and EDTA on cyclic adenosine monophosphate-dependent protein kinase/protein kinase A (PKA α ) activity. ADP reagents A and B were added to kinase reactions containing enzyme and substrate. To initiate the kinase reaction, adenosine 5´-triphosphate (ATP) was added to a final concentration of 40 µM. Kinase activity in the presence and absence of 10 mM EDTA was measured after 30-min incubation at room temperature. Data shown are mean ± SEM (n = 3). (F) Effect of ADP assay reagents on casein kinase 1 activity. ADP reagents A and B were added to kinase reactions containing enzyme and substrate. To initiate the kinase reaction, ATP was added to a final concentration of 40 µM. Kinase activity was measured after a 60-min incubation at room temperature. In control assays, kinase reactions were performed for 30 min at room temperature prior to addition of ADP reagents A and B and a further incubation of 30 min at room temperature. Data shown are mean ± SEM (n = 3). RFU = relative fluorescence unit.
The utility of the ADP accumulation assay in this respect was therefore examined. PKAα was potently inhibited by staurosporine (IC 50 = 5.9 nM; Fig. 7A ), consistent with earlier reports. 34 By comparison, CK1 and Jnk2α2 were weakly inhibited by staurosporine with potencies of 0.53 and 2.2 µM, respectively. These are comparable to staurosporine binding constants of 0.69 and 1.1 µM for CK1 and Jnk2α2, respectively, 35 and demonstrate the ability to identify low-affinity inhibitors with this assay. The measurement of low-potency kinase inhibitors is useful in screening, notably for kinases whose combined low activity and high ATP dependency preclude the use of other homogenous methods. 10, 13 The characterization of the mode of action of novel inhibitors is also important, and the mechanism of staurosporine inhibition on PKAα was examined by assessing its effects on activity and ATP dependency. Staurosporine was observed to reduce enzyme activity in a concentration-dependent fashion at all ATP concentrations tested, and the data acquired fitted well to a competitive inhibition model (Fig. 7B) . A K i of 2.0 ± 0.1 nM was derived, which is consistent with published findings (5 nM). 34 Applying noncompetitive and uncompetitive models to the data produced significantly poorer fits (Fig. 7C, D) . The competitive nature of staurosporine inhibition was confirmed by the observation that the inhibitor increased the ATP K m , but not the V max , in a dosedependent manner.
The ADP assay could be applied to the study of tightbinding inhibitor kinetics. Because the K i of such molecules is typically less than 1 nM and therefore not in excess over enzyme concentration, Michealis-Menten kinetics do not apply for tight-binding inhibitors. 36 As a result, competitive tightbinding inhibitors can appear as noncompetitive in action. A standard approach for identifying tight-binding inhibition is to determine the dose-response curve for inhibition. The IC 50 value of a tight-binding competitive inhibitor will track linearly with kinase concentration. To perform such analysis, the assay has to be sufficiently sensitive to measure kinase activity using enzyme concentrations within a factor of 10 of the inhibitor K i . According to the data shown in Figure 2B , the ADP Quest assay is sufficiently sensitive to measure kinase activity using 1 nM or greater for kinases such as PKA, CK1, and Jnk2α2, indicating the suitability of the assay to study tight-binding inhibitor kinetics.
Summary
The ADP assay described above provides a useful technology for measuring kinase activity, kinase kinetics, and inhibitor potency and mode of action using a simple homogenous protocol. The method extends on the commonly used pyruvate kinase/LDH assay previously reported. 25 The use of long wavelength fluorescence detection in the present assay circumvents commonly encountered interference from library compounds, which can serve to quench or augment short wavelength emission. The monitoring of ADP accumulation rather than ATP consumption makes possible assays that contain high ATP concentrations and permits the measurement of kinase activity without the need for significant substrate turnover. Because there is no assayspecific reagent required other than ATP, the method is suitable for monitoring the progress of any enzyme that generates ADP. Indeed, the utility of the assay in HTS for inhibitors of ATPases has recently been demonstrated, 37 although interference through inhibition of enzymes used in the ADP assay could potentially occur in some instances. The ADP assay is therefore a robust generic method for the study of kinase activity with a high tolerance for ATP, compatibility with protein substrates, and sensitivity to measure a wide range of kinase activity. 
